Literature DB >> 12557293

Lack of creatine in muscle and brain in an adult with GAMT deficiency.

Andreas Schulze1, Peter Bachert, Heinz Schlemmer, Inga Harting, Tilman Polster, Gajja S Salomons, Nanda M Verhoeven, Cornelis Jakobs, Brian Fowler, Georg F Hoffmann, Ertan Mayatepek.   

Abstract

Guanidinoacetate methyltransferase deficiency, which so far has been exclusively detected in children, was diagnosed in a 26-year-old man. The full-blown spectrum of clinical symptoms already had been present since infancy without progression of symptoms during adolescence. Cranial magnetic resonance imaging showed normal findings. Ophthalmological examination showed no retinal changes. Besides creatine deficiency in the brain, a distinct lack of phosphocreatine in skeletal muscle was proved by (31)P magnetic resonance spectroscopy. Creatine substitution combined with a guanidinoacetate-lowering diet introduced first at the age of 26 years was shown to be effective by an impressive improvement of epileptic seizures, mental capabilities, and general behavior and by normalization of the (31)P spectrum in the skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12557293     DOI: 10.1002/ana.10455

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  Advances in genetics: what are the benefits for patients?

Authors:  A Munnich
Journal:  J Med Genet       Date:  2005-12-09       Impact factor: 6.318

2.  Characterization of AGAT, GAMT and CT1 in amphioxus: implications for the evolutionary conservation of creatine metabolism related molecules at the invertebrate-to-vertebrate transition.

Authors:  Lifeng Wang; Dongyan Chen; Ying Zhang; Yushuang Lin; Jianwei Li; Hongwei Zhang
Journal:  Dev Genes Evol       Date:  2008-09-05       Impact factor: 0.900

3.  X-linked creatine transporter deficiency: clinical description of a patient with a novel SLC6A8 gene mutation.

Authors:  Maria C Schiaffino; Carlo Bellini; Laura Costabello; Ubaldo Caruso; Cornelis Jakobs; Gajja S Salomons; Eugenio Bonioli
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

Review 4.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

5.  Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells.

Authors:  Qiuwei Xu; Heather Vu; Liping Liu; Ting-Chuan Wang; William H Schaefer
Journal:  J Biomol NMR       Date:  2011-02-26       Impact factor: 2.835

6.  Global developmental delay in guanidionacetate methyltransferase deficiency: differences in formal testing and clinical observation.

Authors:  Krijn T Verbruggen; Wilma A Knijff; Roelineke J Soorani-Lunsing; Paul E Sijens; Nanda M Verhoeven; Gajja S Salomons; Siena M Goorhuis-Brouwer; Francjan J van Spronsen
Journal:  Eur J Pediatr       Date:  2006-12-21       Impact factor: 3.183

Review 7.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

Review 8.  Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; I Gourfinkel-An; O Lyon-Caen; M Baulac; J-M Saudubray; V Navarro
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

Review 9.  Cellular bioenergetics of guanidinoacetic acid: the role of mitochondria.

Authors:  Sergej M Ostojic
Journal:  J Bioenerg Biomembr       Date:  2015-08-09       Impact factor: 2.945

10.  Phosphorylated guanidinoacetate partly compensates for the lack of phosphocreatine in skeletal muscle of mice lacking guanidinoacetate methyltransferase.

Authors:  Hermien E Kan; W Klaas Jan Renema; Dirk Isbrandt; Arend Heerschap
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.